Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease

Histological grading and staging of chronic hepatitis.

Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290 · see citing works

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

D’Amico, G., García–Tsao, G., & Pagliaro, L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 3,195 · see citing works

Global epidemiology of hepatitis C virus infection

Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758 · see citing works

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,146 · see citing works

Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations

Castéra, L., Foucher, J., Bernard, P., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2009) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,157 · see citing works

Serum markers detect the presence of liver fibrosis: A cohort study

Rosenberg, W. M., Voelker, M., Thiel, R. P., Becka, M., Burt, A. D., Schuppan, D., Hübscher, S. G., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,103 · see citing works

Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

Piechnik, S. K., Ferreira, V. M., Dall’Armellina, E., Cochlin, L. E., Greiser, A., Neubauer, S., & Robson, M. D. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-69 · Cited by 670 · see citing works

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

Williams, R. L., Aspinall, R., Bellis, M. A., Camps-Walsh, G., Cramp, M., Dhawan, A. K., Ferguson, J., Forton, D. M., Foster, G. R., Gilmore, S. I., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61838-9 · Cited by 601 · see citing works

Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data

Singh, S., Venkatesh, S. K., Wang, Z., Miller, F. H., Motosugi, U., Low, R. N., Hassanein, T., Asbach, P., Godfrey, E. M., Yin, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.09.046 · Cited by 549 · see citing works

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

Pais, R., Charlotte, F., Fedchuk, L., Bédossa, P., Lebray, P., Poynard, T., & Ratziu, V. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.027 · Cited by 520 · see citing works

EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B

Jury, T. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00378-7 · Cited by 518 · see citing works

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease

Banerjee, R., Pavlides, M., Tunnicliffe, E. M., Piechnik, S. K., Sarania, N., Philips, R., Collier, J. D., Booth, J., Schneider, J. E., Wang, L. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.002 · Cited by 498 · see citing works

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

Wong, V. W., Chu, C. W., Wong, G. L., Chan, R., Chim, A. M., Ong, A., Yeung, D. K., Yiu, K. K., Chu, S. H.-T., Woo, J., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300342 · Cited by 491 · see citing works

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

Parkes, J., Roderick, P. J., Harris, S., Day, C. P., Mutimer, D., Collier, J. D., Lombard, M., Alexander, G., Ramage, J. K., Dusheiko, G. M., et al. (2010) · Gut · doi:10.1136/gut.2009.203166 · Cited by 349 · see citing works

Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

Loomba, R. S., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J. C., Kono, Y., Bhatt, A., et al. (2014) · Hepatology · doi:10.1002/hep.27647 · Cited by 346 · see citing works

Non-invasive assessment of liver fibrosis with impulse elastography: Comparison of Supersonic Shear Imaging with ARFI and FibroScan®

Cassinotto, C., Lapuyade, B., Mouries, A., Hiriart, J., Vergniol, J., Gaye, D., Castain, C., Bail, B. L., Chermak, F., Foucher, J., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.044 · Cited by 325 · see citing works

Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study

Robic, M. A., Procopeț, B., Métivier, S., Péron, J. M., Sèlves, J., Vinel, J., & Bureau, C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.051 · Cited by 307 · see citing works

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies

Castéra, L., Hézode, C., Roudot‐Thoraval, F., Bastie, A., Zafrani, E.-S., Pawlotsky, J., & Dhumeaux, D. (2003) · Gut · doi:10.1136/gut.52.2.288 · Cited by 297 · see citing works

HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Valenti, L. V. C., Fracanzani, A. L., Bugianesi, E., Dongiovanni, P., Galmozzi, E., Vanni, E., Canavesi, E., Lattuada, E., Roviaro, G., Marchesini, G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.013 · Cited by 280 · see citing works

Intra-observer variation in the histopathological assessment of chronic viral hepatitis

Goldin, R. D., Goldin, J. G., Burt, A. D., Dhillon, A. P., Hubscher, S., Wyatt, J. I., & Patel, N. K. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80234-0 · Cited by 153 · see citing works

Repeatability of magnetic resonance elastography for quantification of hepatic stiffness

Hines, C. D. G., Bley, T. A., Lindstrom, M. J., & Reeder, S. B. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22066 · Cited by 150 · see citing works

Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study

Ganne‐Carrié, N., Christidis, C., Chastang, C., Ziol, M., Chapel, F., Imbert‐Bismut, F., Trinchet, J., Guettier, C., & Beaugrand, M. (2000) · Gut · doi:10.1136/gut.46.2.277 · Cited by 137 · see citing works

Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study

Huang, Y., Yang, S., Fu, S.-C., Wang, T., Hsu, C.-K., Chen, D., Hu, J., & Kao, J. (2014) · Hepatology · doi:10.1002/hep.27212 · Cited by 112 · see citing works

MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis

Heye, T. J., Yang, S.-R., Bock, M., Brost, S., Weigand, K., Longerich, T., Kauczor, H., & Hosch, W. P. (2012) · European Radiology · doi:10.1007/s00330-012-2378-5 · Cited by 107 · see citing works

Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C

Bohte, A. E., Niet, A. D., Jansen, L., Bipat, S., Nederveen, A. J., Verheij, J., Terpstra, V., Sinkus, R., van Nieuwkerk, K. M. J., de Knegt, R. J., et al. (2013) · European Radiology · doi:10.1007/s00330-013-3046-0 · Cited by 105 · see citing works

Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis

Ichikawa, S., Motosugi, U., Morisaka, H., Sano, K., Ichikawa, T., Tatsumi, A., Enomoto, N., Matsuda, M., Fujii, H., & Onishi, H. (2014) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2014.10.003 · Cited by 98 · see citing works

Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers

Poynard, T., Ingiliz, P., Elkrief, L., Munteanu, M., Lebray, P., Morra, R., Messous, D., Imbert‐Bismut, F., Roulot, D. M., Benhamou, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003857 · Cited by 91 · see citing works

Role of magnetic resonance elastography in compensated and decompensated liver disease

Asrani, S. K., Talwalkar, J. A., Kamath, P. S., Shah, V. H., Saracino, G., Jennings, L. W., Gross, J. B., Venkatesh, S. K., & Ehman, R. L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.016 · Cited by 87 · see citing works

Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases

Nascimbeni, F., Lebray, P., Fedchuk, L., Oliveira, C. P., Alvares-da-Silva, M. R., Varault, A., Ingiliz, P., Ngo, Y., de Torres, M., Munteanu, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.037 · Cited by 82 · see citing works

Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014

Torok, N. J., Dranoff, J. A., Schuppan, D., & Friedman, S. L. (2015) · Hepatology · doi:10.1002/hep.27720 · Cited by 70 · see citing works

Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation

Kim, K., Park, M., Kim, I., Kiefer, B., Chung, W., Kim, M., & Kim, K. W. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23620 · Cited by 63 · see citing works

MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score

Haimerl, M., Verloh, N., Fellner, C., Zeman, F., Teufel, A., Feigl, S. F., Schreyer, A. G., Stroszczynski, C., & Wiggermann, P. (2014) · Scientific Reports · doi:10.1038/srep05621 · Cited by 63 · see citing works

Steatosis and fibrosis in patients with chronic hepatitis C

Wyatt, J. I., Baker, H., Prasad, P., Gong, Y. Y., & Millson, C. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009357 · Cited by 58 · see citing works

Evolution of hepatic steatosis in patients with advanced hepatitis C

Lok, A. S.-F., Everhart, J. E., Chung, R. T., Kim, H., Everson, G. T., Hoefs, J. C., Greenson, J. K., Sterling, R. K., Lindsay, K. L., Lee, W. M., et al. (2009) · Hepatology · doi:10.1002/hep.22865 · Cited by 56 · see citing works

Food and drug administration′s critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies

Mahajan, R., & Gupta, K. (2010) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.72130 · Cited by 49 · see citing works

The impact of diabetes and obesity on liver histology in patients with hepatitis C

Friedenberg, F. K., Pungpapong, S., Zaeri, N., & Braitman, L. E. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00256.x · Cited by 37 · see citing works

Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery

Rawlins, S., Mullen, C. M., Simon, H. M., Kim, T., Landas, S. K., Walser, M. S., & Levine, R. A. (2013) · Gastroenterology report · doi:10.1093/gastro/got006 · Cited by 30 · see citing works

EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210 · see citing works

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 510 · see citing works

Challenges and opportunities in NASH drug development

Harrison, S. A., Allen, A. M., Dubourg, J., Noureddin, M., & Alkhouri, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02242-6 · Cited by 353 · see citing works

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions

Lonardo, A., Nascimbeni, F., Targher, G., Bernardi, M., Bonino, F., Bugianesi, E., Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.147 · Cited by 306 · see citing works

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Harrison, S. A., Gawrieh, S., Roberts, K., Lisanti, C. J., Schwope, R. B., Cebe, K. M., Paradis, V., Bedossa, P., Aldridge Whitehead, J. M., Labourdette, A., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.034 · Cited by 293 · see citing works

Noninvasive Diagnosis of NAFLD and NASH

Piazzolla, V., & Mangia, A. (2020) · Cells · doi:10.3390/cells9041005 · Cited by 237 · see citing works

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

Iwakiri, Y., & Trebicka, J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100316 · Cited by 237 · see citing works

Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes

Levelt, E., Pavlides, M., Banerjee, R., Mahmod, M., Kelly, C., Sellwood, J., Ariga, R., Thomas, S., Francis, J., Rodgers, C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.597 · Cited by 222 · see citing works

Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity

Pavlides, M., Banerjee, R., Tunnicliffe, E. M., Kelly, M., Collier, J. D., Wang, L. M., Fleming, K. A., Cobbold, J., Robson, M. D., Neubauer, S., et al. (2016) · Liver International · doi:10.1111/liv.13284 · Cited by 197 · see citing works

Nonalcoholic fatty liver disease: Evolving paradigms

Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 197 · see citing works

Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis

Parisinos, C. A., Wilman, H. R., Thomas, E. L., Kelly, M., Nicholls, R. C., McGonigle, J., Neubauer, S., Hingorani, A. D., Patel, R. S., Hemingway, H., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.032 · Cited by 148 · see citing works

Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis

Andersson, A., Kelly, M., Imajo, K., Nakajima, A., Fallowfield, J. A., Hirschfield, G., Pavlides, M., Sanyal, A. J., Noureddin, M., Banerjee, R., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.041 · Cited by 148 · see citing works

Liver MRI: From basic protocol to advanced techniques

Donato, H., França, M., Candelária, I., & Caseiro‐Alves, F. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.05.028 · Cited by 139 · see citing works

Breakthroughs in therapies for NASH and remaining challenges

Ratziu, V., Francque, S., & Sanyal, A. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.002 · Cited by 132 · see citing works

Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases

Fang, C., An, J., Bruno, A. G., Cai, X.-J., Fan, J., Fujimoto, J., Golfieri, R., Hao, X., Jiang, H., Jiao, L. R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10052-y · Cited by 131 · see citing works

Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver

Bachtiar, V., Kelly, M. D., Wilman, H. R., Jacobs, J., Newbould, R., Kelly, C. J., Gyngell, M. L., Groves, K. E., McKay, A., Herlihy, A. H., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214921 · Cited by 117 · see citing works

Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions

Loomba, R. S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.028 · Cited by 112 · see citing works

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis

Dennis, A., Kelly, M., Fernandes, C. C., Mouchti, S., Fallowfield, J. A., Hirschfield, G. M., Pavlides, M., Harrison, S. A., Chakravarthy, M. V., Banerjee, R., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.575843 · Cited by 109 · see citing works

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease

Eddowes, P. J., McDonald, N., Davies, N. P., Semple, S. I. K., Kendall, T. J., Hodson, J. A., Newsome, P. N., Flintham, R., Wesołowski, R., Blake, L., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14469 · Cited by 104 · see citing works

Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases

Mojtahed, A., Kelly, M., Herlihy, A. H., Kin, S., Wilman, H., McKay, A., Kelly, M., Milanesi, M., Neubauer, S., Thomas, E. L., et al. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1701-2 · Cited by 100 · see citing works

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

Ratziu, V., Harrison, S. A., Loustaud-Ratti, V., Bureau, C., Lawitz, E., Abdelmalek, M., Alkhouri, N., Francque, S., Girma, H., Darteil, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.023 · Cited by 101 · see citing works

Association of Liver Fibrosis With Cardiovascular Diseases in the General Population

Ostovaneh, M. R., Ambale‐Venkatesh, B., Fuji, T., Bakhshi, H., Shah, R. V., Murthy, V. L., Tracy, R. P., Güallar, E., Wu, C. O., Bluemke, D. A., et al. (2018) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007241 · Cited by 100 · see citing works

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

Chin, J. L., Pavlides, M., Moolla, A., & Ryan, J. D. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00159 · Cited by 99 · see citing works

Hepatic steatosis and fibrosis: Non-invasive assessment

Karanjia, R. N., Crossey, M. M. E., Cox, I. J., Fye, H. K. S., Njie, R., Goldin, R. D., & Taylor-Robinson, S. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9880 · Cited by 98 · see citing works

Quantitative Imaging Biomarkers of NAFLD

Kinner, S., Reeder, S. B., & Yokoo, T. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4037-1 · Cited by 90 · see citing works

Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease

Schaapman, J. J., Tushuizen, M. E., Coenraad, M. J., & Lamb, H. J. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27292 · Cited by 85 · see citing works

Multi‐parametric liver tissue characterization using MR fingerprinting: Simultaneous T1, T2, T2*, and fat fraction mapping

Jaubert, O., Arrieta, C., da Cruz, G. J. L., Bustin, A., Schneider, T., Georgiopoulos, G. A., Masci, P. G., Sing‐Long, C., Botnar, R. M., & Prieto, C. (2020) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28311 · Cited by 84 · see citing works

Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses

Topiwala, A., Wang, C., Ebmeier, K. P., Burgess, S., Bell, S., Levey, D. F., Zhou, H., McCracken, C., Roca‐Fernández, A., Petersen, S. E., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004039 · Cited by 84 · see citing works

A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T 1 (shMOLLI- T 1 ) in the liver

Tunnicliffe, E. M., Banerjee, R., Pavlides, M., Neubauer, S., & Robson, M. D. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25392 · Cited by 83 · see citing works

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease

Jayaswal, A. N. A., Levick, C., Selvaraj, E. A., Dennis, A., Booth, J., Collier, J. D., Cobbold, J., Tunnicliffe, E. M., Kelly, M., Barnes, E. J., et al. (2020) · Liver International · doi:10.1111/liv.14625 · Cited by 80 · see citing works

Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum

Cheung, A. C., Neuschwander‐Tetri, B. A., Kleiner, D. E., Schabel, E., Rinella, M. E., Harrison, S. A., Ratziu, V., Sanyal, A. J., Loomba, R. S., Megnien, S. J., et al. (2019) · Hepatology · doi:10.1002/hep.30672 · Cited by 77 · see citing works

Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches

Martinou, E., Pericleous, M., Stefanova, I., Kaur, V., & Angelidi, A. M. (2022) · Diagnostics · doi:10.3390/diagnostics12020407 · Cited by 81 · see citing works

Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study

McDonald, N., Eddowes, P. J., Hodson, J. A., Semple, S. I. K., Davies, N. P., Kelly, M., Kin, S., Phillips, M., Herlihy, A. H., Kendall, T. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27560-5 · Cited by 76 · see citing works

A critical review of endpoints for non-cirrhotic NASH therapeutic trials

Ratziu, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.001 · Cited by 74 · see citing works

Non-alcoholic fatty liver disease in 2016

Townsend, S. A., & Newsome, P. N. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw031 · Cited by 73 · see citing works

Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?

Alkhouri, N., & Feldstein, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.013 · Cited by 69 · see citing works

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03406-8 · Cited by 66 · see citing works

SAM-Med3D: A Vision Foundation Model for General-Purpose Segmentation on Volumetric Medical Images

Wang, H., Guo, S., Ye, J., Deng, Z., Cheng, J., Li, T., Chen, J., Su, Y., Huang, Z., Shen, Y., et al. (2025) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2025.3586694 · Cited by 67 · see citing works

GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms

Ward, L. D., Tu, H.-C., Quenneville, C. B., Tsour, S., Flynn-Carroll, A. O., Parker, M. M., Deaton, A. M., Haslett, P. A. J., Lotta, L. A., Verweij, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24563-1 · Cited by 60 · see citing works

Advances in functional and molecular MRI technologies in chronic liver diseases

Zhou, I. Y., Catalano, O. A., & Caravan, P. D. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.020 · Cited by 58 · see citing works

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease

Lv, S., Jiang, S., Liu, S., Dong, Q., Xin, Y., & Xuan, S. (2018) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00021 · Cited by 57 · see citing works

Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort

Imajo, K., Tetlow, L. A., Dennis, A., Shumbayawonda, E., Mouchti, S., Kendall, T. J., Fryer, E., Yamanaka, S., Honda, Y., Kessoku, T., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i7.609 · Cited by 55 · see citing works

Quantitative MRCP Imaging: Accuracy, Repeatability, Reproducibility, and Cohort‐Derived Normative Ranges

Goldfinger, M., Ridgway, G. R., Ferreira, C., Langford, C., Cheng, L., Kazimianec, A., Borghetto, A., Wright, T. G., Woodward, G., Hassanali, N., et al. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27113 · Cited by 54 · see citing works

Invasive and non-invasive assessment of portal hypertension

Leung, J. C., Loong, T. C., Pang, J., Wei, J. L., & Wong, V. W. (2017) · Hepatology International · doi:10.1007/s12072-017-9795-0 · Cited by 53 · see citing works

Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging

Bradley, C. R., Cox, E. F., Scott, R. A., James, M. W., Kaye, P., Aithal, G. P., Francis, S., & Guha, I. N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.037 · Cited by 53 · see citing works

Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity

Mózes, F. E., Tunnicliffe, E. M., Moolla, A., Marjot, T., Levick, C., Pavlides, M., & Robson, M. D. (2018) · NMR in Biomedicine · doi:10.1002/nbm.4030 · Cited by 52 · see citing works

Multiparametric MR mapping in clinical decision-making for diffuse liver disease

Thomaides-Brears, H. B., Lepe, R., Banerjee, R., & Duncker, C. M. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02684-3 · Cited by 50 · see citing works

A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis

Dennis, A., Mouchti, S., Kelly, M., Fallowfield, J. A., Hirschfield, G. M., Pavlides, M., & Banerjee, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-71995-8 · Cited by 49 · see citing works

Clinical application and technical considerations of T 1 & T 2(*) mapping in cardiac, liver, and renal imaging

Dekkers, I. A., & Lamb, H. J. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170825 · Cited by 47 · see citing works

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

Yip, T. C., Lyu, F., Lin, H., Li, G., Yuen, P. C., Wong, V. W., & Wong, G. L. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0426 · Cited by 46 · see citing works

4D flow cardiovascular magnetic resonance derived energetics in the Fontan circulation correlate with exercise capacity and CMR-derived liver fibrosis/congestion

Rijnberg, F. M., Westenberg, J. J. M., van Assen, H. C., Juffermans, J. F., Kroft, L. J. M., van den Boogaard, P. J., Monteros, C. T. E. D. L., Warmerdam, E. G., Leiner, T., Grotenhuis, H. B., et al. (2022) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-022-00854-4 · Cited by 45 · see citing works

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

Kim, J. W., Lee, Y., Park, Y. S., Kim, B., Lee, S. Y., Yeon, J. E., & Lee, C. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-59601-3 · Cited by 44 · see citing works

Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Mak, A. L., Lee, J., van Dijk, A., Vali, Y., Aithal, G. P., Schattenberg, J. M., Anstee, Q. M., Brosnan, M. J., Zafarmand, M. H., Ramsoekh, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121920 · Cited by 44 · see citing works

Current and Potential Therapies Targeting Inflammation in NASH

Albhaisi, S. A. M., & Noureddin, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.767314 · Cited by 44 · see citing works

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)

Brennan, P., Macmillan, M. T., Manship, T. A., Moroni, F., Glover, A., Graham, C., Semple, S. I. K., Morris, D. M., Fraser, A. R., Pass, C., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053190 · Cited by 41 · see citing works

Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)

Han, M. A. T., Saouaf, R., Ayoub, W. S., Todo, T., Mena, E., & Noureddin, M. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1299573 · Cited by 40 · see citing works

Imaging of Hepatic Fibrosis

Mathew, R. P., & Venkatesh, S. K. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0652-7 · Cited by 40 · see citing works

Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy

Li, J., Liu, H., Zhang, C., Yang, S., Wang, Y., Chen, W., Li, X., & Wang, D. (2019) · European Radiology · doi:10.1007/s00330-019-06335-0 · Cited by 40 · see citing works

Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study

Levick, C., Phillips‐Hughes, J., Collier, J. D., Banerjee, R., Cobbold, J., Wang, L. M., Piechnik, S. K., Robson, M. D., Neubauer, S., Barnes, E. J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221066 · Cited by 40 · see citing works

Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis

Zhou, I. Y., Jordan, V. C., Rotile, N. J., Akam, E. A., Krishnan, S., Arora, G., Krishnan, H., Slattery, H., Warner, N., Mercaldo, N. D., et al. (2020) · Radiology · doi:10.1148/radiol.2020192118 · Cited by 40 · see citing works

Confounding factors of non-invasive tests for nonalcoholic fatty liver disease

Wai, J. W., Fu, C., & Wong, V. W. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01686-8 · Cited by 41 · see citing works

Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity

Arndtz, K., Shumbayawonda, E., Hodson, J. A., Eddowes, P. J., Dennis, A., Thomaides-Brears, H. B., Mouchti, S., Kelly, M., Banerjee, R., Neubauer, S., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1687 · Cited by 40 · see citing works

Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis

Serai, S. D., Trout, A. T., Miethke, A. G., Diaz, E. S., Xanthakos, S. A., & Dillman, J. R. (2018) · Pediatric Radiology · doi:10.1007/s00247-018-4083-2 · Cited by 39 · see citing works

Liver MR relaxometry at 3T – segmental normal T1 and T2* values in patients without focal or diffuse liver disease and in patients with increased liver fat and elevated liver stiffness

Obmann, V. C., Mertineit, N., Marx, C., Berzigotti, A., Ebner, L., Heverhagen, J. T., Christe, A., & Huber, A. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-44377-y · Cited by 39 · see citing works

Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease

Scorletti, E., Afolabi, P. R., Miles, E. A., Smith, D. E., Almehmadi, A., Alshathry, A. S., Moyses, H. E., Clough, G. F., Wright, M., Patel, J., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.05.010 · Cited by 38 · see citing works

Noninvasive imaging assessment of portal hypertension

Kennedy, P., Bane, O., Hectors, S. J. C. G., Fischman, A. M., Schiano, T. D., Lewis, S. C., & Taouli, B. A. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02729-7 · Cited by 38 · see citing works

T1 mapping of the liver and the spleen in patients with liver fibrosis—does normalization to the blood pool increase the predictive value?

Obmann, V. C., Berzigotti, A., Catucci, D., Ebner, L., Gräni, C., Heverhagen, J. T., Christe, A., & Huber, A. T. (2020) · European Radiology · doi:10.1007/s00330-020-07447-8 · Cited by 37 · see citing works

Evaluation of variable flip angle, MOLLI, SASHA, and IR-SNAPSHOT pulse sequences for T1 relaxometry and extracellular volume imaging of the pancreas and liver

Tirkes, T., Zhao, X., Lin, C., Stuckey, A. J., Li, L., Giri, S., & Nickel, D. M. (2019) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-019-00762-2 · Cited by 36 · see citing works

Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era

Ünal, E., İdilman, İ. S., & Karçaaltıncaba, M. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1271710 · Cited by 35 · see citing works

Increased extracellular volume in the liver of pediatric Fontan patients

de Lange, C., Reichert, M. J. E., Pagano, J. J., Seed, M., Yoo, S., Broberg, C. S., Lam, C. Z., & Grosse‐Wortmann, L. (2019) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-019-0545-4 · Cited by 35 · see citing works

Diffusion MRI Derived per Area Vessel Density as a Surrogate Biomarker for Detecting Viral Hepatitis B-Induced Liver Fibrosis: A Proof-of-Concept Study

Xiao, B., Huang, H., Wang, L., Qiu, S.-W., Guo, S., & Wáng, Y. X. J. (2020) · SLAS TECHNOLOGY · doi:10.1177/2472630320915838 · Cited by 34 · see citing works

Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial

Amerikanou, C., Kanoni, S., Kaliora, A. C., Barone, A., Bjelan, M., D’Auria, G., Gioxari, A., Gosalbes, M. J., Mouchti, S., Stathopoulou, M. G., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001178 · Cited by 33 · see citing works

Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions

Kadi, D., Loomba, R. S., & Bashir, M. R. (2024) · Radiology · doi:10.1148/radiol.222695 · Cited by 32 · see citing works

Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Wang, Y., Song, S. J., Jiang, Y., Lai, J. C., Wong, G. L., Wong, V. W., & Yip, T. C. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0246 · Cited by 32 · see citing works

High performance of intravoxel incoherent motion diffusion MRI in detecting viral hepatitis-b induced liver fibrosis

Huang, H., Che‐Nordin, N., Wang, L., Xiao, B., Chevallier, O., Yun, Y., Guo, S., & Wáng, Y. X. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2018.12.33 · Cited by 32 · see citing works

Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla

Gilligan, L. A., Dillman, J. R., Tkach, J. A., Xanthakos, S. A., Gill, J. K., & Trout, A. T. (2019) · Pediatric Radiology · doi:10.1007/s00247-019-04411-7 · Cited by 32 · see citing works

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort

Beyer, C., Hutton, C., Andersson, A., Imajo, K., Nakajima, A., Kiker, D., Banerjee, R., & Dennis, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249491 · Cited by 31 · see citing works

Validation of a standardized MRI method for liver fat and T2* quantification

Hutton, C., Gyngell, M. L., Milanesi, M., Bagur, A. T., & Brady, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204175 · Cited by 31 · see citing works

Quantitative MRI of the liver: Evaluation of extracellular volume fraction and other quantitative parameters in comparison to MR elastography for the assessment of hepatopathy

Kupczyk, P. A., Mesropyan, N., Isaak, A., Endler, C., Faron, A., Kuetting, D. L. R., Sprinkart, A. M., Mädler, B., Thomas, D., Attenberger, U. I., et al. (2020) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2020.12.005 · Cited by 30 · see citing works

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease

Rebelos, E., Iozzo, P., Guzzardi, M. A., Brunetto, M. R., & Bonino, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i30.4999 · Cited by 29 · see citing works

Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease

Grąt, K., Grąt, M., & Rowiński, O. (2020) · Biomedicines · doi:10.3390/biomedicines8090298 · Cited by 28 · see citing works

Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes

Waddell, T., Bagur, A. T., Cunha, D., Thomaides-Brears, H. B., Banerjee, R., Cuthbertson, D. J., Brown, E. E., Cusi, K. J., Després, J., & Brady, M. (2022) · Obesity · doi:10.1002/oby.23425 · Cited by 27 · see citing works

Deep Quantitative Liver Segmentation and Vessel Exclusion to Assist in Liver Assessment

Irving, B., Hutton, C., Dennis, A., Vikal, S., Mavar, M., Kelly, M., & Brady, J. M. (2017) · Communications in computer and information science · doi:10.1007/978-3-319-60964-5_58 · Cited by 27 · see citing works

Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease

Jayakumar, S., Harrison, S. A., & Loomba, R. S. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0296-8 · Cited by 26 · see citing works

Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis

Janowski, K., Shumbayawonda, E., Dennis, A., Kelly, M., Bachtiar, V., DeBrota, D. J., Langford, C., Thomaides-Brears, H. B., Pronicki, M., Grajkowska, W., et al. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002930 · Cited by 26 · see citing works

Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders

Sofias, A. M., Lorenzi, F. D., Peña, Q., Shalmani, A. A., Vucur, M., Wang, J., Kiessling, F. M., Shi, Y., Consolino, L., Storm, G., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113831 · Cited by 27 · see citing works

Simultaneous comprehensive liver T1, T2, , T1ρ, and fat fraction characterization with MR fingerprinting

Velasco, C., da Cruz, G. J. L., Jaubert, O., Lavín, B., Botnar, R. M., & Prieto, C. (2021) · Magnetic Resonance in Medicine · doi:10.1002/mrm.29089 · Cited by 26 · see citing works

FAP-catalyzed in situ self-assembly of magnetic resonance imaging probe for early and precise staging of liver fibrosis

Wu, Z., Zeng, W., Yang, W., Yi, J., Liu, D., Xu, Y., Liu, C. X., Bian, K., Wang, H., & Zhang, B. (2025) · Science Advances · doi:10.1126/sciadv.adt6082 · Cited by 25 · see citing works

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Caussy, C., & Johansson, L. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.134 · Cited by 24 · see citing works

Hepatic Steatosis, Rather Than Underlying Obesity, Increases the Risk of Infection and Hospitalization for COVID-19

Roca‐Fernández, A., Dennis, A., Nicholls, R. C., McGonigle, J., Kelly, M., Banerjee, R., Banerjee, A., & Sanyal, A. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.636637 · Cited by 25 · see citing works

Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis

Heneghan, M. A., Shumbayawonda, E., Dennis, A., Ahmed, R. Z., Rahim, M. N., Ney, M., Smith, L., Kelly, M., Banerjee, R., & Culver, E. L. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101325 · Cited by 25 · see citing works

Noninvasive MRI Native T1 Mapping Detects Response to MYCN -targeted Therapies in the Th- MYCN Model of Neuroblastoma

Zormpas‐Petridis, K., Poon, E., Clarke, M., Jerome, N. P., Boult, J. K. R., Blackledge, M., Carceller, F., Koers, A., Barone, G., Pearson, A. D. J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0133 · Cited by 25 · see citing works

Evolving role of magnetic resonance techniques in primary sclerosing cholangitis

Selvaraj, E. A., Culver, E. L., Bungay, H. K., Bailey, A. A., Chapman, R. W., & Pavlides, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i6.644 · Cited by 24 · see citing works

Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research

Mancini, M., Summers, P. E., Faita, F., Brunetto, M. R., Callea, F., Nicola, A. D., Lascio, N. D., Farinati, F., Gastaldelli, A., Gridelli, B. G., et al. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i2.231 · Cited by 24 · see citing works

Abbreviated mpMRI protocol for diffuse liver disease: a practical approach for evaluation and follow-up of NAFLD

Cunha, G. M., Villela‐Nogueira, C. A., Bergman, A., & Lopes, F. P. P. L. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1504-5 · Cited by 23 · see citing works

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?

Papachristodoulou, A., Kavvadas, D., Karamitsos, A., Papamitsou, T., Chatzidimitriou, M., & Sioga, A. (2021) · Pediatric Reports · doi:10.3390/pediatric13020039 · Cited by 23 · see citing works

Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications

Hydes, T., Brown, E. E., Hamid, A., Bateman, A. C., & Cuthbertson, D. J. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.07.012 · Cited by 22 · see citing works

Physical activity is inversely associated with hepatic fibro-inflammation: A population-based cohort study using UK Biobank data

Sherry, A. P., Willis, S. A., Yates, T. E., Johnson, W., Razieh, C., Sargeant, J. A., Malaikah, S., Stensel, D. J., Aithal, G. P., & King, J. A. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100622 · Cited by 22 · see citing works

Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus

Jayaswal, A. N. A., Levick, C., Collier, J. D., Tunnicliffe, E. M., Kelly, M. D., Neubauer, S., Barnes, E. J., & Pavlides, M. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02860-5 · Cited by 21 · see citing works

Reply to: “Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: A cautionary note on a promising technique”

Pavlides, M., Banerjee, R., Kelly, M., Robson, M. D., Neubauer, S., & Barnes, E. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.022 · Cited by 1 · see citing works

Magnetic resonance imaging metrics and the predictability of adverse outcomes in on‐treatment Asian chronic hepatitis B

Hui, R. W., Chiu, K. W.-H., Mak, L., Chang, H., Cheung, K. S., Fung, J., Yuen, M., & Seto, W. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15846 · Cited by 5 · see citing works

Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: A cautionary note on a promising technique

Chouhan, M. D., Ambler, G., Mookerjee, R. P., & Taylor, S. A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.026 · Cited by 4 · see citing works

Stratification of disease severity in patients with liver fibrosis, cirrhosis and portal hypertension using novel multiparametric magnetic resonance imaging techniques

Jayaswal, A. N. A. (2019) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-e9kok69dk

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease

Jayaswal, A. N. A., Levick, C., Selvaraj, E. A., Dennis, A., Booth, J., Collier, J. D., Cobbold, J., Tunnicliffe, E. M., Kelly, M., Barnes, E. J., et al. (2020) · Liver International · doi:10.1111/liv.14625 · Cited by 80 · see citing works